Scholars Central

EditorialPublished 2012

Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers

Authors: Da-Yong Lu, Ting Ren Lu, Shan Cao

Metabolomics:Open Access

Volume 2 · Issue 5 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A major obstacle to control cancer growth and metastases in patients is the widespread inappropriate use of anticancer drugs. Individualized cancer chemotherapy (ICC) has been attracting increasing attentions in medical circle and will continue to show beneficial outcome in the future. This review addresses this issue by discussing one specific strategy of ICC, biomarker-oriented therapy. Many longstanding key debates and future trends are discussed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Metabolomics:Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMetabolomics:Open Access
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Da-Yong Lu”
  • BylineArticles whose byline prints “Ting Ren Lu”
  • BylineArticles whose byline prints “Shan Cao”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels